Radiosurgical boost for primary high-grade gliomas

Area of Science:

• Neurosurgery
• Radiation Oncology
• Oncology

Background:

• High-grade gliomas are aggressive brain tumors with poor prognoses.
• External beam radiotherapy is a standard treatment, but survival benefits can be limited.
• The role of radiosurgical boost in conjunction with radiotherapy requires further investigation.

Purpose of the Study:

• To retrospectively evaluate the survival outcomes of patients with high-grade gliomas treated with external beam radiotherapy, with or without a radiosurgical boost.

Main Methods:

• A retrospective analysis of 32 patients with high-grade gliomas treated between July 1993 and April 1998.
• Patients were stratified into radiotherapy alone (control) and radiotherapy with radiosurgical boost groups.
• Inclusion criteria included age >18, histological confirmation, curative intent, unifocal, supratentorial tumors, and RPA classes III-VI.

Main Results:

• The median survival time was significantly longer in the radiosurgery group (21.4 months) compared to the control group (11.6 months) (p=0.0254).
• Patients with Karnofsky Performance Status (KPS) >80 showed a marked survival benefit with radiosurgery (53.9 months vs. 11.0 months, p=0.0103).
• Radiosurgery was identified as an independent factor correlated with improved survival on Cox model analysis.

Conclusions:

• A radiosurgical boost may offer a survival advantage for patients with high-grade gliomas, especially those in RPA classes III-VI and with KPS >80.
• These findings suggest radiosurgery as a potentially valuable addition to standard radiotherapy for selected glioma patients.
• Further validation through randomized controlled trials is necessary to confirm the definitive role of radiosurgical boost.